Completed OBSERVATIONAL NCT00927992

Study Evaluating Liver Transplantation in Haemophilia Patients in Spain

Liver Transplantation in Haemophilia Patients in Spain

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer

Interventions Epidemiological Non interventional

Updated 10 times since 2017 Last updated: Dec 20, 2012 Started: Jul 31, 2009 Primary completion: Jun 30, 2010 Completion: Jun 30, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00927992, this observational or N/A phase trial focuses on Hemophilia and Hemophilia B and remains completed. Sponsored by Wyeth is now a wholly owned subsidiary of Pfizer, it has been updated 10 times since 2009, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

10 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2023 — Jul 2024 [monthly]

Completed
Dec 2022 — Jan 2023 [monthly]

Completed
Dec 2021 — Dec 2022 [monthly]

Completed

▶ Show 5 earlier versions

Jan 2021 — Dec 2021 [monthly]

Completed
Sep 2020 — Jan 2021 [monthly]

Completed
Jun 2018 — Sep 2020 [monthly]

Completed
Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None
Jan 2017 — Apr 2018 [monthly]

Completed NA

First recorded

Jul 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Wyeth is now a wholly owned subsidiary of Pfizer

Data source: Wyeth is now a wholly owned subsidiary of Pfizer

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.